Estimation of vaccine efficacy against acquisition of pneumococcal carriage.
about
Mathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and WalesUsing the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and WalesPopulation genomic datasets describing the post-vaccine evolutionary epidemiology of Streptococcus pneumoniaeUsing pneumococcal carriage data to monitor postvaccination changes in invasive disease.Using Pneumococcal Carriage Data to Monitor Postvaccination Changes in the Incidence of Pneumococcal Otitis Media.Outbreaks of Streptococcus pneumoniae carriage in day care cohorts in Finland - implications for elimination of transmissionPathogen evolution and the immunological niche.The two variants of the Streptococcus pneumoniae pilus 1 RrgA adhesin retain the same function and elicit cross-protection in vivo.Pneumococcal transmission and disease in silico: a microsimulation model of the indirect effects of vaccination.Selective and genetic constraints on pneumococcal serotype switching.Interaction of Vaccination and Reduction of Antibiotic Use Drives Unexpected Increase of Pneumococcal Meningitis.Streptococcus pneumoniae colonisation in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine.Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes.New Pneumococcal Carriage Acquired in Association with Acute Respiratory Infection Is Prone to Cause Otitis MediaSerotype Distribution and Antimicrobial Sensitivity Profile of Streptococcus pneumoniae Carried in Healthy Toddlers before PCV13 Introduction in Niamey, Niger.Geographic variation in pneumococcal vaccine efficacy estimated from dynamic modeling of epidemiological data post-PCV7Estimating strain-specific and overall efficacy of polyvalent vaccines against recurrent pathogens from a cross-sectional study.Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model.A mathematical model of serotype replacement in pneumococcal carriage following vaccination.Streptococcus pneumoniae oropharyngeal colonization in school-age children and adolescents with type 1 diabetes mellitus: Impact of the heptavalent pneumococcal conjugate vaccine.Pneumococcal carriage in sub-Saharan Africa--a systematic review.The fundamental link between pneumococcal carriage and disease.Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies.Prevalence of Heptavalent Vaccine-related Pneumococcal Serotypes in Nasopharyngeal carrier in children under five years old in Shahrekord, Iran by Multiplex-PCR during 2010- 2011.Estimation and interpretation of heterogeneous vaccine efficacy against recurrent infections.Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines.Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.Prevalence and serotype distribution of nasopharyngeal carriage of Streptococcus pneumoniae in China: a meta-analysis.The impact of specific and non-specific immunity on the ecology of Streptococcus pneumoniae and the implications for vaccination.Frequency-dependent selection in vaccine-associated pneumococcal population dynamics.Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India.
P2860
Q28727057-4B2DD694-4B4D-480B-92B4-3A2385DFC82EQ28742003-19D23896-CCF0-4742-B45F-757470D47FF2Q30399651-C6A1F48D-CF7E-49BC-8071-03978C171C7CQ30665494-15BE5494-1FC3-474A-A4BF-DEDF50A9A3CEQ31136900-09AC9498-1070-4768-A08A-F9C2CF677605Q33475186-5CF3AC6C-E22E-4275-BC2E-DAFDED0A9FB6Q34078369-78098531-1181-4F6E-9F6D-BF112374E6E1Q34309687-E78159F0-C891-461A-87E6-2423CB50E8F7Q34606511-28F04063-CC44-4D1A-9FA2-5C5FA5078401Q35590891-F61201BF-1E41-4A03-A68C-14F3DC6B0FCEQ35716556-F8EA3BD4-CC82-41CB-B61D-506769CC468CQ35890971-7F11A2BB-2DD7-46E9-8F1A-AF13C5A165A3Q35927343-4AEF49A6-1F44-4C42-B0AD-2A1171A71D50Q36039264-7FCD2FBB-8EC0-4B0E-A7F9-4D6A3D22487EQ36253841-5E1089F4-F7FC-4F8C-BDCA-AF179AF95CF6Q36399999-F1FBF661-A4CE-45A2-9772-E61D902F4EF8Q36754230-515E4A80-9ACB-4BC0-A664-858CF4F47F63Q36894814-462FDB3A-F2C4-4E57-8EDF-9BDB570788CBQ37255818-9D1A97AB-3277-49B3-ACF9-F924785200BCQ37309259-AC8B32FD-5CB4-4DDD-A374-042C3EF25338Q37495709-F94E2204-22CD-4698-A4D9-FF3B664B0078Q38036689-C8EF34F5-D94A-4FB8-88E2-FCC57E48E08AQ39043548-3B706C53-D490-44AB-A27F-8D15A89E5CE3Q39134568-AB56E810-4FB1-472C-BD89-2FB5EB529B79Q40084457-E0537876-8D74-47B1-99D3-8B34798202CEQ40943510-DE739D27-7C9E-4828-91DE-3E044F58AA2BQ42257384-9F6F5E2D-97F1-4D63-8006-869C0D808E05Q47108090-E5C58443-F703-403F-986E-EACCA2FF03FEQ51157834-50CCDDF1-26A8-4AAE-8BA8-F4C3692B83BFQ54333644-3D3CD08A-4C19-4006-84CB-73393C97980FQ55126608-76ECEF11-7A2D-4000-A28E-0668D09ABA19
P2860
Estimation of vaccine efficacy against acquisition of pneumococcal carriage.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Estimation of vaccine efficacy against acquisition of pneumococcal carriage.
@en
Estimation of vaccine efficacy against acquisition of pneumococcal carriage.
@nl
type
label
Estimation of vaccine efficacy against acquisition of pneumococcal carriage.
@en
Estimation of vaccine efficacy against acquisition of pneumococcal carriage.
@nl
prefLabel
Estimation of vaccine efficacy against acquisition of pneumococcal carriage.
@en
Estimation of vaccine efficacy against acquisition of pneumococcal carriage.
@nl
P2093
P1433
P1476
Estimation of vaccine efficacy against acquisition of pneumococcal carriage.
@en
P2093
Hanna Rinta-Kokko
Kari Auranen
Noga Givon-Lavi
P304
P356
10.1016/J.VACCINE.2009.04.009
P407
P577
2009-04-23T00:00:00Z